Your browser doesn't support javascript.
loading
Efficacy and safety of raltitrexed plus S-1 versus regorafenib in patients with refractory metastatic colorectal cancer: a real-world propensity score matching study.
Zhou, Yu-Wen; Wang, Jia-Ling; Li, Qing-Fang; He, Yuan-Lin; Li, Lin-Juan; Liu, Rui-Zhi; Chen, Ye; Zhang, Shuang; Qiu, Meng; Liu, Ji-Yan.
Affiliation
  • Zhou YW; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Wang JL; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Li QF; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • He YL; West China School of Medicine, Sichuan University, Chengdu, China.
  • Li LJ; Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Liu RZ; Department of Medicine and Life Science, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
  • Chen Y; Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Zhang S; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
  • Qiu M; Department of Abdominal Oncology, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Xiang Street, Chengdu 610041, Sichuan Province, China.
  • Liu JY; Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, 37 Guoxue Xiang Street, Chengdu 610041, Sichuan Province, China.
Therap Adv Gastroenterol ; 15: 17562848221098246, 2022.
Article in En | MEDLINE | ID: mdl-35601804

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Therap Adv Gastroenterol Year: 2022 Type: Article Affiliation country: China

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Therap Adv Gastroenterol Year: 2022 Type: Article Affiliation country: China